The FDA approved a new Alzheimer’s treatment called donanemab on Tuesday. It is designed to help patients in the early stages of the disease. CBS News chief medical correspondent Dr. Jon LaPook explains what to know.
Each weekday morning, "CBS Mornings" co-hosts Gayle King, Tony Dokoupil and Nate Burleson bring you the latest breaking news, smart conversation and in-depth feature reporting. "CBS Mornings" airs weekdays at 7 a.m. on CBS and stream it at 8 a.m. ET on the CBS News app.
Subscribe to "CBS Mornings" on YouTube: https://youtube.com/CBSMornings
Watch CBS News 24/7: https://cbsnews.com/live/
Download the CBS News app: https://cbsnews.com/mobile/
Follow "CBS Mornings" on Instagram: https://instagram.com/cbsmornings/
Like "CBS Mornings" on Facebook: https://facebook.com/CBSMornings
Follow "CBS Mornings" on X: https://twitter.com/CBSMornings
Subscribe to our newsletter: https://cbsnews.com/newsletters/
Try Paramount+ free: https://paramountplus.com/?ftag=PPM-05-10aeh8h
For video licensing inquiries, contact: licensing@veritone.com
